Results 251 to 260 of about 115,505 (280)
Some of the next articles are maybe not open access.
Mechanical Circulatory Support
2019Mechanical circulatory support (MCS) offers life-saving treatment options for patients with advanced heart failure, cardiogenic shock, and acute cardiopulmonary failure. With the development of short-term, long-term, left-sided, right-sided, biventricular, and cardiopulmonary support options, the complexity surrounding this field has evolved ...
Adam C. Adler +2 more
+4 more sources
Mechanical circulatory support
Abstract Mechanical circulatory support (MCS) is a collection of technologies that offer short- or long-term ventricular assistance for patients with heart failure. Ventricular assist devices (VADs) are available to support the left ventricle (LVAD), right ventricle (RVAD), or both (BiVAD).Roy S. Gardner +3 more
+5 more sources
Mechanical Circulatory Support
1998Acute cardiogenic shock has a mortality rate of 80–90%, that of chronic terminal heart failure is about 50%. For this reason, mechanical circulatory support systems were developed both for acute bridging of a potentially reversible cardiogenic shock and for longer term therapy in the form of a bridge-to-transplantation method.
Michael Böhm, Erland Erdmann
openaire +1 more source
Mechanical circulatory support
The Annals of Thoracic Surgery, 2001MECHANICAL CIRCULATORY SUPPORT By Wayne E.
openaire +2 more sources
Mechanical circulatory support
2023Abstract Mechanical circulatory support (MCS) has evolved dramatically over the last 50 years. Circulatory pumps are routinely being used to treat the spectrum of presentations ranging from cardiogenic shock (short-term, for acute haemodynamic restoration) advanced heart failure (long-term, to improve quality and duration of life). Short-
Mandeep Mehra, Finn Gustafsson
openaire +1 more source
Mechanical Circulatory Support Devices
AACN Advanced Critical Care, 2006Dana, Shannon +3 more
openaire +2 more sources
Mechanical Circulatory Support
2016Due to the marked increase in the number of advanced (end stage) heart failure patients and the lack of suitable donors to allow heart transplantation, the majority of these patients do not survive. Recent improvements in technology have allowed development of durable ventricular assist devices that can support an increasing number of patients for ...
Liviu Klein, Lucian Dorobanţu
openaire +1 more source

